About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Hematologic Malignancies
Lung Cancers
Breast Cancers
General Oncology
Palliative Care
Business & Clinical Practice
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
I
ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL
By
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
FEATURING
Ian W. Flinn
By
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
FEATURING
Ian W. Flinn
217 views
March 16, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
20:59
Exelixis
Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…
Feat.
S. Ratnam
Hematologic Malignancies
06:39
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Ch…
Feat.
I. Flinn
07:09
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL
Feat.
I. Flinn
11:47
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate C…
Feat.
J. Berdeja
09:00
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among …
Feat.
J. Berdeja
12:36
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Future Directions in Multiple Myeloma: Selinexor Approval, Venetocla…
Feat.
J. Berdeja
18:23
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & L…
Feat.
I. Flinn